# Siphox

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/siphox

- Industry: Medical Devices & Equipment
- Headquarters: Burlington, US
- Website: www.siphoxhealth.com
- Total disclosed funding: $17M
- Latest round: Series A (Jan 5, 2023)
- Investors on record: 14

## About

Based in Massachusetts, US, and co-founded by Diedrik Vermeulen (CEO) and Michael Dubrovsky (CPO) in 2020, Siphox, Inc. operates as a developer and provider of at-home test kits for blood testing. In July 2023, the firm raised USD 10 million in seed funding led by investors Khosla Ventures and Y Combinator, with participation from other investors CEP America, LLC, Longevity Tech Fund, M2I2, Metaplanet Holdings, and Rsquared.

The company offers direct-to-consumer health and wellness paradigms to address the increasing prevalence of chronic diseases. The firm offers at-home health testing kits using advanced silicon photonic biosensors. The kits are made through the utilization of biochemistry and photonic chip technology to deliver more biomarker data faster and with minimal blood volume. Also, SiPhox leverages silicon photonics, using semiconductor techniques, to fabricate photonic circuits that miniaturize complex optical systems used in central labs for blood testing. This enables lab-quality results in a consumer-friendly form factor. The product, SiPhox Health at-home test kit, measures 17 blood biomarkers related to inflammation, hormonal health, metabolic fitness, and cardiovascular health. The kit provides customers with insights into their health baseline and empowers them to make proactive lifestyle and diet choices for better health.

## Funding rounds

- Series A, Jan 5, 2023, $17M — Intel Capital, Khosla Ventures, Y Combinator, Alumni Ventures Group, Rsquared, Metaplanet Holdings, LongeVC, Longevity Tech Fund, CEP America, LLC, Kortex Ventures, Shorewind Capital, Overlap Holdings, Duke Capital Partners, M2I2

## Investors

- Intel Capital (https://capitalatlas.ai/funds/intel-capital) — Series A
- Khosla Ventures (https://capitalatlas.ai/funds/khosla-ventures) — Series A
- Y Combinator (https://capitalatlas.ai/funds/y-combinator) — Series A
- Alumni Ventures Group (https://capitalatlas.ai/funds/alumni-ventures-group) — Series A
- Rsquared — Series A
- Metaplanet Holdings (https://capitalatlas.ai/funds/metaplanet-holdings) — Series A
- LongeVC (https://capitalatlas.ai/funds/longevc) — Series A
- Longevity Tech Fund (https://capitalatlas.ai/funds/longevity-tech-fund) — Series A
- CEP America, LLC — Series A
- Kortex Ventures (https://capitalatlas.ai/funds/kortex-ventures) — Series A
- Shorewind Capital (https://capitalatlas.ai/funds/shorewind-capital) — Series A
- Overlap Holdings (https://capitalatlas.ai/funds/overlap-holdings) — Series A
- Duke Capital Partners (https://capitalatlas.ai/funds/duke-capital-partners) — Series A
- M2I2 — Series A